Skip to main content
ANLON HEALTHCARE LIMITED logo

ANLON HEALTHCARE LIMITED — Investor Relations & Filings

Ticker · AHCL ISIN · INE0Y8W01017 LEI · 254900IAINYLU31JGU83 BSE.NS Manufacturing
Open in API
Filings indexed 98 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country IN India
Listing BSE.NS AHCL

About ANLON HEALTHCARE LIMITED

https://anlon.in/

Anlon Healthcare Limited specializes in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company’s product portfolio addresses multiple therapeutic areas, including cardiovascular, anti-diabetic, and anti-infective medicine. Core operations involve chemical synthesis, formulation development, and contract manufacturing services. By maintaining a focus on technical innovation and quality standards, the organization provides integrated healthcare solutions to a global clientele. Its business model encompasses the entire value chain from laboratory-scale R&D to commercial-scale production, ensuring the supply of essential medicinal components and finished products to various healthcare providers and distributors.

Recent filings

Filing Released Lang Actions
We have attached herewith investor presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.
Regulatory Filings
2026-06-03 English
Investor Presentation
Regulatory Filings
2026-06-03 English
Copy of newspaper publication dated May 30, 2026 regarding publication of extract of Audited Financial Results (Standalone and Consolidated) for Quarter and Year ended 31st March, 2026.
Report Publication Announcement Classification · 85% confidence The document is a short compliance letter to the stock exchanges under SEBI LODR Regulations 30 and 47, stating that a newspaper advertisement (an extract of audited financial results for the quarter and year ended March 31, 2026) has been published and is attached for record. It does not itself contain the full report, but simply announces the publication of the extract. According to the “Menu vs Meal” and report‐publication rules, this is a report‐publication announcement, not the actual financial report.
2026-05-30 English
Intimation for Press Release of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended March 31, 2026.
Earnings Release Classification · 89% confidence The document is a stock exchange disclosure under SEBI LODR Regulation 30 titled “Intimation for Press release of Audited Financial Results (Standalone and Consolidated) for the Quarter & Year Ended March 31, 2026.” It provides headline financial metrics (Total Income, EBITDA, PAT) for Q4 and FY26, along with management commentary. This constitutes the company’s initial public announcement of quarterly and full-year audited results, matching the definition of an Earnings Release (ER), rather than a full annual report or a mere report publication notice. FY 2026
2026-05-30 English
Press Release
Earnings Release Classification · 90% confidence The document is a press release filed under Regulation 30 of SEBI listing rules announcing the company’s audited standalone and consolidated financial results for Q4 and full-year March 31, 2026. It provides summary financial highlights (revenue, EBITDA, PAT growth) and management commentary, matching the definition of an initial earnings release with key results rather than the full statutory report. Therefore, it is classified as an Earnings Release. FY 2026
2026-05-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 88% confidence The document is a short exchange filing under SEBI LODR Regulations (Reg 30 & 47), submitting a newspaper advertisement of the extract of audited financial results for the quarter/year ended March 31, 2026. It contains no substantive financial statements itself and merely attaches a publication notice for compliance. This fits the definition of a routine regulatory announcement rather than the full report, so it should be classified as a general Regulatory Filing (RNS).
2026-05-30 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.